Can acid reflux medications cause migraines? New research links PPIs, H2 blockers, and antacids to a higher risk of headaches ...

The guidelines support use of PPIs, dietary therapy, and biologics for EoE, and stress the importance of addressing both the ...

My husband died aged 72 from prostate cancer. He used talcum powder daily for 50 years and I read recently that it was linked ...

Handa Therapeutics acquires US FDA approved chronic myeloid leukaemia drug, Phyrago tablets from Nanocopoeia: Taipei, Taiwan Friday, January 17, 2025, 15:00 Hrs [IST] Handa Pharma ...

PHYRAGO Represents the First and Only Improved Version of SPRYCEL® That Can Be Safely Co-administered With Gastric Acid-Reducing Agents TAIPEI, TAIWAN / ACCESSWIRE / January 15, 2025 / Handa Pharmaceu ...

TAIPEI, TAIWAN / ACCESSWIRE / January 15, 2025 / Handa Pharmaceuticals, Inc. ("Handa") (6620.TWO) announced that its U.S.

In the ABYSS (Assessment of Beta-Blocker Interruption 1 Year After an Uncomplicated Myocardial Infarction on Safety and Symptomatic Cardiac Events Requiring Hospitalization) trial, interruption of ...

Examples include proton pump inhibitors, aka PPIs, and histamine H2-receptor antagonists, or H2 blockers, which are used to reduce acid reflux symptoms and might be available over the counter.

To block beta-adrenergic receptors, there are two classes of medication: β1-selective inhibitors and non-selective beta-blockers. Non-selective beta-blockers inhibit signaling from all three beta ...

Alpha-1 adrenergic receptor antagonist (α1-ARA) are well established treatment for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS). Since BPH and erectile dysfunction ...

Epidermal growth factor receptor (EGFR) is expressed in 50% of NSCLCs, and its expression is correlated with poor prognosis. These two factors make EGFR and its family members prime candidates for ...